A mong various types of Chiari malformation, type I malformation (CM-1) is described as caudal displacement of cerebellar tonsils below foramen magnum.
There are various treatment approaches for treating Chiari type I malformation with syringomyelia. Despite various choices, consensus for one particular approach is lacking. The objective of this study is to fi nd out the clinical and radiological outcome of standard posterior fossa decompression incorporating removal of C1 arch with lax duroplasty in such cases.
A retrospective study based on data acquired from a single tertiary center were analyzed. All cases who underwent posterior fossa decompression incorporating removal of C1 arch with lax duroplasty over a period of fi ve years were included and their clinical and radiological progress were recorded during OPD follow up at 6 months.
Out of 21 cases, occipital headache with nape of neck pain was the predominant complaint accounting to 71% followed by sensory symptoms and motor weakness, 61% and 33% respectively. Pain resolved in 93%, weakness in 71% and sensory symptoms in 69% of the cases. Only one patient developed hydrocephalus requiring shunting. Radiological improvement of syringomyelia were documented in 76.1% of the patients. There was no mortality.
Posterior fossa decompression incorporating removal of C1 arch and lax duroplasty is a safe approach with good outcome in patients with Chiari I malformation with syringomyelia.
Keywords: chiari malformation, syringomyelia, posterior fossa decompression, outcomes the symptoms and associated syringomyelia that warrants treatment and the asymptomatic ones found incidentally are better left alone. 10 Various theories are postulated to be the root cause of the problems but common fi nal step is the disruption of the normal CSF fl ow through foramen magnum. 6 Two main types of surgical modalities have been advocated for the treatment of CM-I. Posterior fossa decompression with or without duroplasty (PFDD or PFD, respectively) and the other is shunting of syrinx to subarachnoid space in the spine or coelomic cavity. 8 Posterior fossa decompression still remains the primary surgical technique for the treatment of CM-I because the shunt technique produces a risk of iatrogenic spinal cord injury. However, whether duroplasty alone without tonsillar ablation or adhesiolysis is suffi cient during posterior fossa decompression remains controversial. 5, 8 In this study, we look into the outcome of posterior fossa decompression with C1 arch removal with lax duroplasty for Chiari type I malformation with syringomyelia
Methods
A descriptive retrospective study was conducted after permission from institutional review board. Data were reviewed from the institute's archives. All patients who had undergone Posterior fossa decompression with C1 arch removal with lax duroplasty over the period of fi ve years (January 2013 to December 2017) were included. The demographics of the patients were noted. Their presenting symptoms were noted from the patients fi le and the follow up of these symptoms at 6 months were done at OPD or over telephone. Reports from the radiologists of the institute were used to confi rm the radiological resolution of syrinx.
Posterior fossa decompression of 3 by 3 cm squared with removal of C1 arch, opening the dura above and below the foramen magnum with lax duroplasty was considered standard approach ( Figure 1 ). Operative notes were thoroughly checked to exclude any patient whose procedure were different from the standard.
Results
A total of 21 patient underwent the standard approach during study period. The age ranged from 13 to 52 years with median age of 31 (IQR 15). Out of them 11 (52%) were females and 10 (48%) were male.
Clinical presentation
Occipital headache with nape of the neck pain was the most common symptom seen in 15 patients (71%). This was aggravated while coughing or sneezing (Valsalva maneuver) in 66.66%. The second most frequent symptom was sensory disturbances seen among 12 patients (57%). Symptoms varied from tingling and burning sensation of bilateral upper limb to diminished sensation and numbness. Motor weakness was seen in 7 (33%) patients and was mostly distal parts of the upper limbs (Figure 2 ).
Resolution of symptoms at 6 months
Among the patients who had pain as the predominant symptom 86.7% had subjective resolution of pain. Improvement in the sensory symptoms were seen in 66.7%. The patients who had motor weakness had improved in 57.1%. Complete radiological resolution of syrinx was seen in 16 patients (76.1%) (Figure 3) . 
Complications
Surgical site infection requiring debridement and secondary suturing occurred in 1 patient. One patient developed hydrocephalus 2 weeks after the primary surgery requiring hydrocephalus (Table 1) .
Discussion
Most patients in our study were young adults with almost equal male and female distribution. Most patients with Chiari Malformation presented with headache with nape of neck pain followed by sensory symptoms are similar to the published literature. 9 The resolution of symptoms has been reported to be as high as 87% and 97% in independent studies by Munsi I et al and Chen JC et all respectively.
3,11 Our study shows resolution of pain, motor weakness and sensory disturbances were 93%, 71% and 69%. Lower rates were likely because of short follow up of 6 months.
A meta-analysis of 5 retrospective and 2 prospective study done by Durham et al concluded that posterior fossa decompression with duroplasty is associated with a lower risk of reoperation than posterior fossa decompression alone but has a greater risk for cerebrospinal fl uid-related complications. There was no signifi cant difference between the 2 operative techniques with respect to clinical improvement or decrease in syringomyelia. 
Conclusions
Posterior fossa decompression incorporating removal of C1 arch and lax duroplasty is a safe approach with good outcome in patients with Chiari I malformation with syringomyelia. Comparative study with other surgical procedures for this condition is required to fi nd out the best treatment option for these patients.
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